IIPLA News
Wednesday, August 5, 2026

Cosmax Earns Korean IP Office Recognition for Excellence in Employee Invention Rewards, Surpasses 2,000 Patent Filings

Leading cosmetics ODM firm Cosmax strengthens IP competitiveness through systematic employee invention incentives and robust patent portfolio expansion

IIPLA News Deskanonymous access0 articles left this week
Cosmax Earns Korean IP Office Recognition for Excellence in Employee Invention Rewards, Surpasses 2,000 Patent Filings

Cosmax, a prominent global cosmetics original development manufacturing (ODM) company, has been officially certified by the Korean Intellectual Property Office (KIPO) as an Outstanding Employee Invention Reward Company. This certification acknowledges Cosmax’s systematic and exemplary approach to rewarding employees for their research and development achievements, reinforcing the company’s commitment to fostering innovation.

Announced on August 5, the certification is awarded to small and medium-sized enterprises that have established and effectively operate employee invention reward regulations. KIPO’s comprehensive evaluation considers the level of system operation, reward performance, and the cultivation of an invention-encouraging culture within the company.

Cosmax operates a comprehensive reward system that incentivizes employees not only in research and development but also across production, design, and other sectors. This system covers patent, utility model, design, and trademark applications. Between 2021 and the first quarter of 2026, Cosmax distributed over 230 million won in rewards for 1,765 employee inventions, encompassing patents, designs, and trademarks.

The company has steadily expanded its intellectual property portfolio, boasting more than 2,000 cumulative patent applications and over 900 registered patents to date. Cosmax asserts that its overall intellectual property holdings, including trademark rights, represent the largest scale within the cosmetics ODM industry.

To manage its IP assets, Cosmax maintains a dedicated intellectual property organization that oversees the entire process from application strategy formulation to rights acquisition and utilization. This system enables the company to swiftly convert research achievements into enforceable rights, thereby enhancing its business competitiveness—a factor positively noted in the certification evaluation.

As a certified Outstanding Employee Invention Reward Company, Cosmax is now eligible for administrative benefits such as priority examination and reductions in registration fees when applying for patents, utility models, and designs. The company intends to leverage these advantages to improve the efficiency of its research and development investments and to accelerate the pace of securing technology rights.

A Cosmax official commented, "We have continuously advanced our reward system so that employees' creative ideas can lead to new technologies and business competitiveness. Going forward, we will expand technological innovation and intellectual property creation based on an effective employee invention system."

This certification marks a significant milestone in Cosmax’s ongoing efforts to strengthen its intellectual property competitiveness and to foster a culture of innovation among its workforce, positioning the company for sustained growth in the competitive cosmetics ODM market.

Share This Article
Ready-to-post copy includes the article link.

Cosmax Earns Korean IP Office Recognition for Excellence in Employee Invention Rewards, Surpasses 2,000 Patent Filings Cosmax, a global cosmetics original development manufacturing company, has been certified by the Korean Intellectual Property Office as an Outstanding Employee Invention Reward Company. The accolade recognizes Cosmax’s... Read the full IIPLA article: https://iipla.org/news/cosmax-earns-korean-ip-office-recognition-for-excellence-in-employee-invention-rewards-surpasses-2-000-patent-filings

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Paul Weiss Expands Life Sciences Practice with Partner Ian Edvalson in San Francisco

Paul, Weiss, Rifkind, Wharton & Garrison has appointed Ian Edvalson as a partner in its San Francisco office, strengthening the firm’s life sciences transactions and intellectual property practices. Edvalson brings extensive experience advising biopharmaceutical and medical technology companies on licensing, collabora…

Friday, August 7, 2026
PatentsGlobal

Mexican Patent Law Overhaul Demands Early Strategic Planning from Applicants

In the first half of 2026, Mexico implemented sweeping patent reforms that significantly alter how patent applications are prepared, filed, and prosecuted. Key changes include a reduction in the number of substantive office actions and a mandated one-year examination timeline, compelling applicants to adopt earlier an…

Friday, August 7, 2026
PatentsGlobal

China Advances Comprehensive Pharmaceutical IP Protection with New Regulatory Frameworks

China’s pharmaceutical sector is rapidly evolving from generic manufacturing to innovative drug development, supported by a robust intellectual property protection system. Key measures including regulatory data protection, patent term extensions, patent linkage mechanisms, and strengthened judicial and administrative…

Friday, August 7, 2026
PatentsGlobal

T&G Global Posts Strong First-Half Results Driven by Premium Apple Sales

T&G Global reported a 2.6% revenue increase to $572.3 million for the six months ending June 30, 2024, led by a 6.1% rise in its Apples division revenue to $550.9 million. Operating profit grew 30% to $11.6 million before impairment adjustments related to the sale of T&G Fresh businesses. The company highlighted signi…

Friday, August 7, 2026